168 related articles for article (PubMed ID: 15003313)
21. Structure-function relationships of interleukin-3. An analysis based on the function and binding characteristics of a series of interspecies chimera of gibbon and murine interleukin-3.
Kaushansky K; Shoemaker SG; Broudy VC; Lin NL; Matous JV; Alderman EM; Aghajanian JD; Szklut PJ; VanDyke RE; Pearce MK
J Clin Invest; 1992 Nov; 90(5):1879-88. PubMed ID: 1385477
[TBL] [Abstract][Full Text] [Related]
22. Characterization of diphtheria fusion proteins targeted to the human interleukin-3 receptor.
Frankel AE; Ramage J; Kiser M; Alexander R; Kucera G; Miller MS
Protein Eng; 2000 Aug; 13(8):575-81. PubMed ID: 10964987
[TBL] [Abstract][Full Text] [Related]
23. Modified DT-IL2 fusion toxin targeting uniquely IL2Ralpha expressing leukemia cell lines - Construction and characterization.
Potala S; Verma RS
J Biotechnol; 2010 Jul; 148(2-3):147-55. PubMed ID: 20580754
[TBL] [Abstract][Full Text] [Related]
24. [Construction and expression of the fusion protein DT389-hIL-13 and its cytotoxicity to glioma cell lines].
Tuo HZ; Wang JW; Wang DX; Li JM; Ouyang J; Hong T
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):1024-8. PubMed ID: 15312540
[TBL] [Abstract][Full Text] [Related]
25. Receptor binding kinetics of human IL-3 variants with altered proliferative activity.
Klein BK; Shieh JJ; Grabbe E; Li X; Welply JK; McKearn JP
Biochem Biophys Res Commun; 2001 Nov; 288(5):1244-9. PubMed ID: 11700046
[TBL] [Abstract][Full Text] [Related]
26. Interleukin 4 receptor targeted cytotoxicity: genetic construction and in vivo immunosuppressive activity of a diphtheria toxin-related murine interleukin 4 fusion protein.
Lakkis F; Steele A; Pacheco-Silva A; Rubin-Kelley V; Strom TB; Murphy JR
Eur J Immunol; 1991 Sep; 21(9):2253-8. PubMed ID: 1679715
[TBL] [Abstract][Full Text] [Related]
27. Most immature T-ALLs express Ra-IL3 (CD123): possible target for DT-IL3 therapy.
Lhermitte L; de Labarthe A; Dupret C; Lapillonne H; Millien C; Landman-Parker J; Hermine O; Baruchel A; Sigaux F; Macintyre E; Asnafi V
Leukemia; 2006 Oct; 20(10):1908-10. PubMed ID: 16900212
[No Abstract] [Full Text] [Related]
28. A bispecific immunotoxin (DTAT13) targeting human IL-13 receptor (IL-13R) and urokinase-type plasminogen activator receptor (uPAR) in a mouse xenograft model.
Todhunter DA; Hall WA; Rustamzadeh E; Shu Y; Doumbia SO; Vallera DA
Protein Eng Des Sel; 2004 Feb; 17(2):157-64. PubMed ID: 15047912
[TBL] [Abstract][Full Text] [Related]
29. Genetic assembly and selective toxicity of diphtheria-toxin-related polypeptide hormone fusion proteins.
Murphy JR; Bishai W; Williams D; Bacha P; Borowski M; Parker K; Boyd J; Waters C; Strom TB
Biochem Soc Symp; 1987; 53():9-23. PubMed ID: 2847744
[TBL] [Abstract][Full Text] [Related]
30. Induction of apoptosis in multidrug-resistant and radiation-resistant acute myeloid leukemia cells by a recombinant fusion toxin directed against the human granulocyte macrophage colony-stimulating factor receptor.
Perentesis JP; Waddick KG; Bendel AE; Shao Y; Warman BE; Chandan-Langlie M; Uckun FM
Clin Cancer Res; 1997 Mar; 3(3):347-55. PubMed ID: 9815691
[TBL] [Abstract][Full Text] [Related]
31. The efficacy of diphtheria-growth factor fusion proteins is enhanced by co-administration of cytosine arabinoside in an immunodeficient mouse model of human acute myeloid leukemia.
Hogge DE; Feuring-Buske M; Gerhard B; Frankel AE
Leuk Res; 2004 Nov; 28(11):1221-6. PubMed ID: 15380349
[TBL] [Abstract][Full Text] [Related]
32. Characterization and receptor specific toxicity of two diphtheria toxin-related interleukin-3 fusion proteins DAB389-mIL-3 and DAB389-(Gly4Ser)2-mIL-3.
Liger D; vanderSpek JC; Gaillard C; Cansier C; Murphy JR; Leboulch P; Gillet D
FEBS Lett; 1997 Apr; 406(1-2):157-61. PubMed ID: 9109408
[TBL] [Abstract][Full Text] [Related]
33. Malignant progenitors from patients with CD87+ acute myelogenous leukemia are sensitive to a diphtheria toxin-urokinase fusion protein.
Frankel AE; Beran M; Hogge DE; Powell BL; Thorburn A; Chen YQ; Vallera DA
Exp Hematol; 2002 Nov; 30(11):1316-23. PubMed ID: 12423685
[TBL] [Abstract][Full Text] [Related]
34. High-level Expression and Characterization of the Fusion Protein Consisting of Diphtheria Toxin and Human Interleukin 6.
Zhang XJ; Li J; Zhang BY; Hong T
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 1998; 30(2):169-173. PubMed ID: 12174278
[TBL] [Abstract][Full Text] [Related]
35. Bioactive IL7-diphtheria fusion toxin secreted by mammalian cells.
Shulga-Morskoy S; Rich BE
Protein Eng Des Sel; 2005 Jan; 18(1):25-31. PubMed ID: 15790577
[TBL] [Abstract][Full Text] [Related]
36. Chimeric fusion proteins--diphtheria toxin-based.
Frankel AE; Powell BL; Vallera DA; Neville DM
Curr Opin Investig Drugs; 2001 Sep; 2(9):1294-301. PubMed ID: 11717818
[TBL] [Abstract][Full Text] [Related]
37. The diphtheria toxin/urokinase fusion protein (DTAT) is selectively toxic to CD87 expressing leukemic cells.
Ramage JG; Vallera DA; Black JH; Aplan PD; Kees UR; Frankel AE
Leuk Res; 2003 Jan; 27(1):79-84. PubMed ID: 12479856
[TBL] [Abstract][Full Text] [Related]
38. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
39. AntiCD3Fv fused to human interleukin-3 deletion variant redirected T cells against human acute myeloid leukemic stem cells.
Fan D; Li Z; Zhang X; Yang Y; Yuan X; Zhang X; Yang M; Zhang Y; Xiong D
J Hematol Oncol; 2015 Feb; 8():18. PubMed ID: 25879549
[TBL] [Abstract][Full Text] [Related]
40. Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitis.
Yarkoni S; Sagiv Y; Kaminitz A; Farkas DL; Askenasy N
Eur J Immunol; 2009 Oct; 39(10):2850-64. PubMed ID: 19735074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
